Association between the urogenital microbiome and surgical treatment response in women undergoing midurethral sling operation for mixed urinary incontinence.


Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
01 2022
Historique:
received: 27 04 2021
revised: 06 07 2021
accepted: 14 07 2021
pubmed: 24 7 2021
medline: 15 2 2022
entrez: 23 7 2021
Statut: ppublish

Résumé

The urogenital microbiome is associated with urgency and mixed urinary incontinence symptoms and differential treatment responses to pharmacotherapy for urgency urinary incontinence. This study aimed to describe whether the preoperative urinary and vaginal microbiomes were associated with surgical treatment responses at 12 months after a midurethral sling operation in women with mixed urinary incontinence. This cohort study compared the preoperative microbiome compositions of urine and vaginal samples from a subset of women undergoing a midurethral sling operation in the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence trial (NCT01959347) and compared the microbiota in women who were surgical responders vs surgical nonresponders. Twelve-month objective response was defined as a ≥70% reduction from baseline urinary incontinence episodes on a 3-day diary. Subjective response was defined as a change from baseline in the Urogenital Distress Inventory scores. Bacterial abundance and beta diversity were assessed using 16S ribosomal RNA sequencing. The primary differential abundance analysis described predominant bacterial operational taxonomic units associated with responders vs nonresponders using unadjusted and age-adjusted linear models. Objective nonresponders (n=28) compared with responders (n=72) were older (58.5±10.7 vs 51.6±10.2 years) and more likely postmenopausal without hormone use (odds ratio, 6.4; 95% confidence interval, 1.8-22.6). Vaginal and urinary microbiota beta diversities were associated with age (P<.05) for both responders and nonresponders. Overall, predominant operational taxonomic units (genera) were Lactobacillus, Gardnerella, Tepidimonas, Escherichia, Streptococcus, and Prevotella. Operational taxonomic units from baseline urine samples were not significantly associated (P threshold=.05) with surgical treatment responses. A greater abundance of baseline vaginal Lactobacillus was associated with an objective response (P=.04) and Prevotella with an objective nonresponse (P=.01). Adjusting for age, only a greater abundance of baseline vaginal Prevotella was associated with an objective nonresponse (P=.01). Moreover, less abundant vaginal operational taxonomic units were associated with objective and subjective responses and persistent urinary incontinence symptoms (P<.05). Women meeting a 70% reduction of urinary incontinence treatment episodes (objective responders) had greater vaginal Lactobacillus at the time of the surgical procedure; however, controlling for age diminished this association. Women not meeting a 70% reduction of urinary incontinence episodes 1 year after a midurethral sling operation had greater vaginal Prevotella at the time of the midurethral sling operation. Further research is needed to determine whether therapy altering the vaginal microbiome may impact surgical treatment responses in women with mixed urinary incontinence.

Sections du résumé

BACKGROUND
The urogenital microbiome is associated with urgency and mixed urinary incontinence symptoms and differential treatment responses to pharmacotherapy for urgency urinary incontinence.
OBJECTIVE
This study aimed to describe whether the preoperative urinary and vaginal microbiomes were associated with surgical treatment responses at 12 months after a midurethral sling operation in women with mixed urinary incontinence.
STUDY DESIGN
This cohort study compared the preoperative microbiome compositions of urine and vaginal samples from a subset of women undergoing a midurethral sling operation in the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence trial (NCT01959347) and compared the microbiota in women who were surgical responders vs surgical nonresponders. Twelve-month objective response was defined as a ≥70% reduction from baseline urinary incontinence episodes on a 3-day diary. Subjective response was defined as a change from baseline in the Urogenital Distress Inventory scores. Bacterial abundance and beta diversity were assessed using 16S ribosomal RNA sequencing. The primary differential abundance analysis described predominant bacterial operational taxonomic units associated with responders vs nonresponders using unadjusted and age-adjusted linear models.
RESULTS
Objective nonresponders (n=28) compared with responders (n=72) were older (58.5±10.7 vs 51.6±10.2 years) and more likely postmenopausal without hormone use (odds ratio, 6.4; 95% confidence interval, 1.8-22.6). Vaginal and urinary microbiota beta diversities were associated with age (P<.05) for both responders and nonresponders. Overall, predominant operational taxonomic units (genera) were Lactobacillus, Gardnerella, Tepidimonas, Escherichia, Streptococcus, and Prevotella. Operational taxonomic units from baseline urine samples were not significantly associated (P threshold=.05) with surgical treatment responses. A greater abundance of baseline vaginal Lactobacillus was associated with an objective response (P=.04) and Prevotella with an objective nonresponse (P=.01). Adjusting for age, only a greater abundance of baseline vaginal Prevotella was associated with an objective nonresponse (P=.01). Moreover, less abundant vaginal operational taxonomic units were associated with objective and subjective responses and persistent urinary incontinence symptoms (P<.05).
CONCLUSION
Women meeting a 70% reduction of urinary incontinence treatment episodes (objective responders) had greater vaginal Lactobacillus at the time of the surgical procedure; however, controlling for age diminished this association. Women not meeting a 70% reduction of urinary incontinence episodes 1 year after a midurethral sling operation had greater vaginal Prevotella at the time of the midurethral sling operation. Further research is needed to determine whether therapy altering the vaginal microbiome may impact surgical treatment responses in women with mixed urinary incontinence.

Identifiants

pubmed: 34297969
pii: S0002-9378(21)00794-8
doi: 10.1016/j.ajog.2021.07.008
pmc: PMC8748268
mid: NIHMS1726255
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01959347']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

93.e1-93.e15

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069010
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK110417
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U24 HD069031
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Br J Surg. 2018 Jan;105(2):e131-e141
pubmed: 29341151
BMC Microbiol. 2019 Feb 18;19(1):42
pubmed: 30777006
Int Urogynecol J. 2016 Oct;27(10):1479-90
pubmed: 27287818
Obstet Gynecol. 2020 Sep;136(3):482-491
pubmed: 32769647
Nat Rev Urol. 2018 Dec;15(12):735-749
pubmed: 30315209
Antimicrob Agents Chemother. 2000 Aug;44(8):2130-2
pubmed: 10898686
Int Urogynecol J. 2017 May;28(5):711-720
pubmed: 27738739
Nat Commun. 2018 Apr 19;9(1):1557
pubmed: 29674608
J Infect Dis. 2019 Aug 30;220(7):1085-1088
pubmed: 30715397
GMS Infect Dis. 2020 Mar 26;8:Doc02
pubmed: 32373427
Front Cell Infect Microbiol. 2019 May 01;9:133
pubmed: 31119104
Int Urogynecol J. 2018 Dec;29(12):1785-1795
pubmed: 29909556
Open Forum Infect Dis. 2015 Mar 23;2(2):ofv029
pubmed: 26380331
Am J Obstet Gynecol. 2020 Nov;223(5):727.e1-727.e11
pubmed: 32791124
Front Microbiol. 2019 Feb 14;10:193
pubmed: 30837959
Int Urogynecol J. 2014 Sep;25(9):1179-84
pubmed: 24515544
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Am J Obstet Gynecol. 2020 Feb;222(2):154.e1-154.e10
pubmed: 31421123
Sci Rep. 2018 Aug 14;8(1):12157
pubmed: 30108246
Int Urogynecol J. 2016 May;27(5):723-33
pubmed: 26423260
JAMA. 2019 Sep 17;322(11):1066-1076
pubmed: 31529007
Qual Life Res. 1994 Oct;3(5):291-306
pubmed: 7841963
JPEN J Parenter Enteral Nutr. 2013 Mar;37(2):243-53
pubmed: 22750803
mBio. 2014 Jul 08;5(4):e01283-14
pubmed: 25006228
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Clin Microbiol Rev. 2015 Jul;28(3):687-720
pubmed: 26062576

Auteurs

Holly E Richter (HE)

Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, AL. Electronic address: hrichter@uabmc.edu.

Megan U Carnes (MU)

Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, NC.

Yuko M Komesu (YM)

Department of Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM.

Emily S Lukacz (ES)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Diego, San Diego, CA.

Lily Arya (L)

Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, PA.

Megan Bradley (M)

Department of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Rebecca G Rogers (RG)

Department of Obstetrics and Gynecology, Dell Medical School, The University of Texas at Austin, Austin, TX.

Vivian W Sung (VW)

Department of Obstetrics and Gynecology, Alpert Medical School of Brown University, Providence, RI.

Nazema Y Siddiqui (NY)

Department of Obstetrics and Gynecology, Duke University, Durham, NC.

Benjamin Carper (B)

Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, NC.

Donna Mazloomdoost (D)

Gynecologic Health and Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.

Darryl Dinwiddie (D)

Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM; Clinical Translational Science Center, University of New Mexico Health Sciences, Albuquerque, NM.

Marie G Gantz (MG)

Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH